Cross‐sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study
Addiction2014Vol. 109(7), pp. 1101–1109
Citations Over TimeTop 10% of 2014 papers
Peggy van der Pol, Nienke Liebregts, Tibor M. Brunt, Jan van Amsterdam, Ron de Graaf, Dirk J. Korf, Wim van den Brink, Margriet van Laar
Abstract
Cannabis users titrate their delta-9-tetrahydrocannabinol intake by inhaling lower volumes of smoke when smoking strong joints, but this does not fully compensate for the higher cannabis doses per joint when using strong cannabis. Thus, users of more potent cannabis are generally exposed to more delta-9-tetrahydrocannabinol. Smoking behaviour appears to be a stronger predictor for cannabis dependence severity than monthly delta-9-tetrahydrocannabinol dose.
Related Papers
- → An efficient new cannabinoid antiemetic in pediatric oncology(1995)183 cited
- → Delta-8 tetrahydrocannabinol, delta-10 tetrahydrocannabinol, and tetrahydrocannabinol-O acetate exposures reported to America’s Poison Centers(2024)11 cited
- → Effects of the cannabinoid CB1 receptor antagonist, SR141716A, after Δ9-tetrahydrocannabinol withdrawal(2000)43 cited
- → Apparent affinity estimates of rimonabant in combination with anandamide and chemical analogs of anandamide in rhesus monkeys discriminating Δ9-tetrahydrocannabinol(2008)21 cited
- → (R)-Methanandamide and Δ9-tetrahydrocannabinol-induced operant rate decreases in rats are not readily antagonized by SR-141716A(2003)27 cited